全基因组甲基化分析揭示了小细胞肺癌患者血液DNA中的差异甲基化基因。

IF 5.1 4区医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL

Precision Clinical Medicine Pub Date : 2022-09-01 DOI:10.1093/pcmedi/pbac017

Yanqi He, Calvin Wei, Zhifu Sun, Julie M Cunningham, Liang Wang, Zong Wei, Ping Yang

引用次数: 2

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Genome-wide methylation profiling reveals differentially methylated genes in blood DNA of small-cell lung cancer patients.

查看原文本刊更多论文

Genome-wide methylation profiling reveals differentially methylated genes in blood DNA of small-cell lung cancer patients.

the epige-netic biomarkers under investigation. We here report a study that identified aberrantly methylated genes between current and former smokers among SCLC patients, revealing a set of candidate biomarkers in peripheral blood DNA for better stratifying patients with high risk.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Precision Clinical Medicine MEDICINE, RESEARCH & EXPERIMENTAL-

CiteScore

10.80

自引率

0.00%

发文量

审稿时长

5 weeks

期刊介绍： Precision Clinical Medicine (PCM) is an international, peer-reviewed, open access journal that provides timely publication of original research articles, case reports, reviews, editorials, and perspectives across the spectrum of precision medicine. The journal's mission is to deliver new theories, methods, and evidence that enhance disease diagnosis, treatment, prevention, and prognosis, thereby establishing a vital communication platform for clinicians and researchers that has the potential to transform medical practice. PCM encompasses all facets of precision medicine, which involves personalized approaches to diagnosis, treatment, and prevention, tailored to individual patients or patient subgroups based on their unique genetic, phenotypic, or psychosocial profiles. The clinical conditions addressed by the journal include a wide range of areas such as cancer, infectious diseases, inherited diseases, complex diseases, and rare diseases.